July 3, 2022



Chemed Shows Rising Relative Price Performance; Still Shy Of Key Benchmark

2 min read

The Relative Strength (RS) Rating for Chemed (CHE) moved up into a new percentile Thursday, as it got a lift from 70 to 74.


When you’re researching the best stocks to buy and watch, be sure to pay attention to relative price strength.

This unique rating identifies technical performance by showing how a stock’s price movement over the last 52 weeks measures up against that of the other stocks in our database.

Over 100 years of market history reveals that the stocks that go on to make the biggest gains typically have an RS Rating north of 80 in the early stages of their moves. See if Chemed can continue to rebound and clear that threshold.

See How IBD Helps You Make More Money In Stocks

Chemed is building a cup without handle with a 539.97 entry. See if the stock can break out in volume at least 40% above average.

Chemed showed 2% earnings growth in its most recent report. Sales rose 1%. Look for the next report on or around Apr. 27.

The company earns the No. 5 rank among its peers in the Diversified Operations industry group. Otter Tail (OTTR) and Crane (CR) are also among the group’s highest-rated stocks.


IBD Stock Rating Upgrades: Rising Relative Strength

Why Should You Use IBD’s Relative Strength Rating?

How Relative Strength Line Can Help You Judge A Stock

Evaluate Any Stock With Stock Ratings, IBD Charts And Stock Checkup

Copyright © All rights reserved. | Newsphere by AF themes.